PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmacology and Toxicology, College of Pharmacy, The University of Arizona, Tucson, Arizona 85721, United States.\', \'Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida 33612, United States.\', \'Department of Chemistry and Biochemistry, The University of Arizona, Tucson, Arizona 85721, United States.\', \'Department of Microbiology, Immunology and Molecular Genetics, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229, United States.\', \'Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.\', \'Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1021/acs.jmedchem.1c00509
?:doi
?:hasPublicationType
?:journal
  • Journal of medicinal chemistry
is ?:pmid of
?:pmid
?:pmid
  • 33891389
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.567
?:rankingScore_hIndex
  • 231
?:title
  • Expedited Approach toward the Rational Design of Noncovalent SARS-CoV-2 Main Protease Inhibitors.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33891389>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33891389>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all